Developer docs
API playgroundTry for free, no card

Search company profiles

Surrey and Sussex Cancer Alliance

Full company profile

uuid00yom1v

Namestring
Surrey and Sussex Cancer Alliance
Legal namestring
Surrey and Sussex Cancer Alliance
Company typeenum
Public
Founded yearint
2019
Descriptiontext

Surrey and Sussex Cancer Alliance (SSCA) is one of 21 NHS England-mandated cancer alliances in England, established in 2019 to lead the transformation of cancer services across the Surrey, Sussex and Frimley footprint — covering three Integrated Care Systems (Frimley, Surrey Heartlands and NHS Sussex) and seven partner NHS acute trusts. The alliance coordinates a portfolio spanning prevention and screening (Lung Cancer Screening, Bowel, Breast, Cervical and HPV programmes), faster diagnosis (28-day Faster Diagnosis Standard, Optimal Timed Pathway toolkits, visual pathway guides), treatment (Systemic Anti-Cancer Treatment programme, radiotherapy), personalised care (Personalised Stratified Follow-Up, prehabilitation and rehabilitation, Holistic Needs Assessments), and innovation (PinPoint Test, eDerma digital dermatology, Colon Capsule Endoscopy). Its digital infrastructure includes the SSCA Cancer Digital Dashboard, the Performance Improvement Resource Hub with the Pathway Analyser Tool, the NHS Futures collaboration platform, and the Cancer Care Map patient-facing resource.

Underlying technology combines pathway-level data aggregation across NHS trusts with selective adoption of machine learning-enabled diagnostics (PinPoint Test blood biomarker analysis) and digital imaging platforms (eDerma). The Cancer Academy delivers workforce education including Advanced Communication Skills, Psychological Support Skills, Operational Support Staff Development, and Cancer as a Long-Term Condition. Innovation adoption is supported by the Kent, Surrey and Sussex Academic Health Science Network, with academic partnerships at the University of Surrey, University of Sussex and Brighton and Sussex Medical School.

SSCA is publicly funded through NHS England allocations and is not a commercial entity — there is no pricing model and no commercial go-to-market. It operates as a partnership coordinator, with delivery executed through the seven regional acute trusts, primary care networks, local authorities, and charity partners including Macmillan Cancer Support, Cancer Research UK and The Prostate Project. The board is chaired by Louise Stead (CEO of Royal Surrey NHS Foundation Trust and Ashford and St Peter's Hospitals NHS Foundation Trust), with Keri Torney as Managing Director and Alex Norman and Sarah Westwell as Co-Medical Directors. As of latest disclosures, the team numbers 45+ staff including programme directors, pathway managers, data analysts and a dedicated communications function, and the alliance is delivering against NHS Long Term Plan targets of 75% of cancers diagnosed at stages 1 and 2 and 55,000 additional five-year cancer survivors annually by 2028.

Short descriptiontext

Surrey and Sussex Cancer Alliance is an NHS England-mandated alliance coordinating cancer care transformation across the Surrey, Sussex and Frimley footprint, working with seven acute trusts, primary care networks, charities and universities to improve screening, diagnosis, treatment and personalised care.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersGuildford, United Kingdom
HQ citystring
Guildford
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cancer care coordination, NHS oncology services, cancer pathway improvement, healthcare alliance services, cancer service commissioning
Industry1 code
1Public Health Governance, Interagency Coordination & Partnerships
CodeHLAJAMADPrimaryYes
NAICS code1 code
  • Religious, Grantmaking, Civic, Professional, and Similar Organizations813
SIC code1 code
  • Services-Health Services8000
Product category
Healthcare Cancer Care Coordination
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1NHS England Core Funding
TypeSubscription Recurring
Description

Funded through NHS England to lead transformation and improvement of cancer care services across Surrey, Sussex and Frimley regions through collaborative partnership working with health and social care organisations

surreyandsussexcanceralliance.nhs.uk
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Surrey and Sussex Cancer Alliance is one of 21 NHS-funded cancer alliances in England that coordinates and improves cancer care delivery across the Surrey, Sussex, and Frimley regions. The alliance works with NHS trusts, integrated care boards, primary care networks, and GP practices to redesign cancer pathways, accelerate early diagnosis, and enhance treatment outcomes for cancer patients. It operates as a regional coordinating body rather than a direct care provider, funded by NHS England.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Three-quarters of lung cancer patients diagnosed at Stage 1 and 2 through screening programme
+5 more records
Product overview1 text field

Surrey and Sussex Cancer Alliance is a NHS partnership organisation coordinating cancer care across Surrey, Sussex and Frimley, not a commercial product company. The organisation provides a coordinated portfolio of cancer care services, programmes and resources including: screening programmes (Lung Cancer Screening, Bowel, Breast, Cervical, HPV vaccination), treatment programmes (SACT, radiotherapy, genomics), personalised care services (PSFU, prehabilitation, holistic needs assessments), and digital tools (Cancer Digital Dashboard, Performance Improvement Resource Hub, Cancer Care Map). The Cancer Academy provides workforce education. Innovation projects include the PinPoint Test using machine learning, eDerma skin cancer pathway technology, and Colon Capsule Endoscopy. These work together within the NHS cancer care framework to improve early diagnosis, treatment outcomes and patient experience across the alliance footprint.

Product and service2 records
1Cancer Pathway Coordination Service
CategoryHealthcare Service Coordination
2Early Diagnosis Improvement Programme
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership17 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Integrated Health and Care System partner working collaboratively on cancer transformation across the Frimley region

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Integrated Care System partner for Surrey Heartlands working on cancer services improvement

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Integrated Care System partner for Sussex region coordinating cancer care transformation

Strategic tierCoreTypeStrategic or Co-development Partner
Description

NHS Integrated Care Board responsible for commissioning cancer services in Frimley area

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Integrated Care Board commissioning cancer services for Surrey Heartlands population

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Integrated Care Board commissioning cancer services across Sussex

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Charity partner providing resources, education, funding and patient support across the cancer pathway including health and wellbeing hub, emotional support, and workforce development

Strategic tierCoreTypeStrategic or Co-development Partner
Description

National cancer charity partner supporting early diagnosis initiatives, screening programmes, and cancer awareness campaigns

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Academic partner providing research capability and education in cancer care

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Academic partner contributing to cancer research and education

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Medical school partner supporting cancer education and training

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

AHSN partner supporting innovation adoption in cancer care

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Patient advocacy partners representing patient voice in cancer service development across Surrey, Sussex and Brighton and Hove

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Charity partner focused on prostate cancer awareness and support

Strategic tierCoreTypeStrategic or Co-development Partner
Description

National NHS body providing strategic direction, funding and performance monitoring for cancer services

Strategic tierCoreTypeStrategic or Co-development Partner
Description

National body supporting cancer workforce education and training development

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Specialist cancer centre within West London Radiotherapy Network providing radiotherapy services

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Surrey and Sussex Cancer Alliance

Healthcare Cancer Care Coordinationsurreyandsussexcanceralliance.nhs.uk

Surrey and Sussex Cancer Alliance is an NHS England-mandated alliance coordinating cancer care transformation across the Surrey, Sussex and Frimley footprint, working with seven acute trusts, primary care networks, charities and universities to improve screening, diagnosis, treatment and personalised care.

What Surrey and Sussex Cancer Alliance does

Surrey and Sussex Cancer Alliance (SSCA) is one of 21 NHS England-mandated cancer alliances in England, established in 2019 to lead the transformation of cancer services across the Surrey, Sussex and Frimley footprint — covering three Integrated Care Systems (Frimley, Surrey Heartlands and NHS Sussex) and seven partner NHS acute trusts. The alliance coordinates a portfolio spanning prevention and screening (Lung Cancer Screening, Bowel, Breast, Cervical and HPV programmes), faster diagnosis (28-day Faster Diagnosis Standard, Optimal Timed Pathway toolkits, visual pathway guides), treatment (Systemic Anti-Cancer Treatment programme, radiotherapy), personalised care (Personalised Stratified Follow-Up, prehabilitation and rehabilitation, Holistic Needs Assessments), and innovation (PinPoint Test, eDerma digital dermatology, Colon Capsule Endoscopy). Its digital infrastructure includes the SSCA Cancer Digital Dashboard, the Performance Improvement Resource Hub with the Pathway Analyser Tool, the NHS Futures collaboration platform, and the Cancer Care Map patient-facing resource.

Underlying technology combines pathway-level data aggregation across NHS trusts with selective adoption of machine learning-enabled diagnostics (PinPoint Test blood biomarker analysis) and digital imaging platforms (eDerma). The Cancer Academy delivers workforce education including Advanced Communication Skills, Psychological Support Skills, Operational Support Staff Development, and Cancer as a Long-Term Condition. Innovation adoption is supported by the Kent, Surrey and Sussex Academic Health Science Network, with academic partnerships at the University of Surrey, University of Sussex and Brighton and Sussex Medical School.

SSCA is publicly funded through NHS England allocations and is not a commercial entity — there is no pricing model and no commercial go-to-market. It operates as a partnership coordinator, with delivery executed through the seven regional acute trusts, primary care networks, local authorities, and charity partners including Macmillan Cancer Support, Cancer Research UK and The Prostate Project. The board is chaired by Louise Stead (CEO of Royal Surrey NHS Foundation Trust and Ashford and St Peter's Hospitals NHS Foundation Trust), with Keri Torney as Managing Director and Alex Norman and Sarah Westwell as Co-Medical Directors. As of latest disclosures, the team numbers 45+ staff including programme directors, pathway managers, data analysts and a dedicated communications function, and the alliance is delivering against NHS Long Term Plan targets of 75% of cancers diagnosed at stages 1 and 2 and 55,000 additional five-year cancer survivors annually by 2028.

Surrey and Sussex Cancer Alliance firmographics

Firmographics
Name
Surrey and Sussex Cancer Alliance
Legal name
Surrey and Sussex Cancer Alliance
Website
https://surreyandsussexcanceralliance.nhs.uk
Company type
Public
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Short description
Surrey and Sussex Cancer Alliance is an NHS England-mandated alliance coordinating cancer care transformation across the Surrey, Sussex and Frimley footprint, working with seven acute trusts, primary care networks, charities and universities to improve screening, diagnosis, treatment and personalised care.
Ownership category
akta.pro rank

Surrey and Sussex Cancer Alliance industry classification

Industry
Product category
Healthcare Cancer Care Coordination
NAICS
Religious, Grantmaking, Civic, Professional, and Similar Organizations (813)
SIC
Services-Health Services (8000)
akta.pro primary industry
Public Health Governance, Interagency Coordination & Partnerships (HLAJAMAD)

Keywords

  • Cancer care coordination
  • NHS oncology services
  • Cancer pathway improvement
  • Healthcare alliance services
  • Cancer service commissioning

Where Surrey and Sussex Cancer Alliance is headquartered

Location

Headquarters

HQ city
Guildford
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Surrey and Sussex Cancer Alliance business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. NHS England Core Funding: Funded through NHS England to lead transformation and improvement of cancer care services across Surrey, Sussex and Frimley regions through collaborative partnership working with health and social care organisations

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Surrey and Sussex Cancer Alliance product offering

Product offering

Core offering

Surrey and Sussex Cancer Alliance is one of 21 NHS-funded cancer alliances in England that coordinates and improves cancer care delivery across the Surrey, Sussex, and Frimley regions. The alliance works with NHS trusts, integrated care boards, primary care networks, and GP practices to redesign cancer pathways, accelerate early diagnosis, and enhance treatment outcomes for cancer patients. It operates as a regional coordinating body rather than a direct care provider, funded by NHS England.

Product overview

Surrey and Sussex Cancer Alliance is a NHS partnership organisation coordinating cancer care across Surrey, Sussex and Frimley, not a commercial product company. The organisation provides a coordinated portfolio of cancer care services, programmes and resources including: screening programmes (Lung Cancer Screening, Bowel, Breast, Cervical, HPV vaccination), treatment programmes (SACT, radiotherapy, genomics), personalised care services (PSFU, prehabilitation, holistic needs assessments), and digital tools (Cancer Digital Dashboard, Performance Improvement Resource Hub, Cancer Care Map). The Cancer Academy provides workforce education. Innovation projects include the PinPoint Test using machine learning, eDerma skin cancer pathway technology, and Colon Capsule Endoscopy. These work together within the NHS cancer care framework to improve early diagnosis, treatment outcomes and patient experience across the alliance footprint.

Differentiator

Problem solved

Functional benefit

Products and services

  • Cancer Pathway Coordination Service
  • Early Diagnosis Improvement Programme

Quantifiable outcome

  • Three-quarters of lung cancer patients diagnosed at Stage 1 and 2 through screening programme
  • +5 more outcomes

Companies that use Surrey and Sussex Cancer Alliance

Customer profile

Named customers8 records

Segments4 records

Ideal customer profiles1 record

Surrey and Sussex Cancer Alliance technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Surrey and Sussex Cancer Alliance partnerships and signals

Strategic signal

Partnerships

17 partnerships are on record, tiered core and supporting.

  • Frimley Health and CarecoreStrategic or Co-development PartnerIntegrated Health and Care System partner working collaboratively on cancer transformation across the Frimley region
  • Surrey Heartlands Health and Care PartnershipcoreStrategic or Co-development PartnerIntegrated Care System partner for Surrey Heartlands working on cancer services improvement
  • Sussex Health and CarecoreStrategic or Co-development PartnerIntegrated Care System partner for Sussex region coordinating cancer care transformation
  • NHS FrimleycoreStrategic or Co-development PartnerNHS Integrated Care Board responsible for commissioning cancer services in Frimley area
  • NHS Surrey HeartlandscoreStrategic or Co-development PartnerIntegrated Care Board commissioning cancer services for Surrey Heartlands population
  • NHS SussexcoreStrategic or Co-development PartnerIntegrated Care Board commissioning cancer services across Sussex
  • Macmillan Cancer SupportcoreStrategic or Co-development PartnerCharity partner providing resources, education, funding and patient support across the cancer pathway including health and wellbeing hub, emotional support, and workforce development
  • Cancer Research UKcoreStrategic or Co-development PartnerNational cancer charity partner supporting early diagnosis initiatives, screening programmes, and cancer awareness campaigns
  • University of SurreysupportingStrategic or Co-development PartnerAcademic partner providing research capability and education in cancer care
  • University of SussexsupportingStrategic or Co-development PartnerAcademic partner contributing to cancer research and education
  • Brighton and Sussex Medical SchoolsupportingStrategic or Co-development PartnerMedical school partner supporting cancer education and training
  • Kent, Surrey and Sussex Academic Health Science NetworksupportingStrategic or Co-development PartnerAHSN partner supporting innovation adoption in cancer care
  • Healthwatch England and Local HealthwatchsupportingStrategic or Co-development PartnerPatient advocacy partners representing patient voice in cancer service development across Surrey, Sussex and Brighton and Hove
  • The Prostate ProjectsupportingStrategic or Co-development PartnerCharity partner focused on prostate cancer awareness and support
  • NHS EnglandcoreStrategic or Co-development PartnerNational NHS body providing strategic direction, funding and performance monitoring for cancer services
  • Health Education EnglandcoreStrategic or Co-development PartnerNational body supporting cancer workforce education and training development
  • Royal Marsden Hospitals NHS Foundation TrustsupportingStrategic or Co-development PartnerSpecialist cancer centre within West London Radiotherapy Network providing radiotherapy services

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Surrey and Sussex Cancer Alliance competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Surrey and Sussex Cancer Alliance social profiles

Digital presence

Surrey and Sussex Cancer Alliance financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Surrey and Sussex Cancer Alliance leadership team

Management profile

Number of profiles

Profiles1 record

Surrey and Sussex Cancer Alliance funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Surrey and Sussex Cancer Alliance M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Surrey and Sussex Cancer Alliance

What does Surrey and Sussex Cancer Alliance do?

Surrey and Sussex Cancer Alliance is one of 21 NHS-funded cancer alliances in England that coordinates and improves cancer care delivery across the Surrey, Sussex, and Frimley regions. The alliance works with NHS trusts, integrated care boards, primary care networks, and GP practices to redesign cancer pathways, accelerate early diagnosis, and enhance treatment outcomes for cancer patients. It operates as a regional coordinating body rather than a direct care provider, funded by NHS England.

Is Surrey and Sussex Cancer Alliance a public or private company?

Surrey and Sussex Cancer Alliance is a public company. It is classified as state government owned and is currently operating.

When was Surrey and Sussex Cancer Alliance founded?

Surrey and Sussex Cancer Alliance was founded in 2019. It employs 11 to 50 people.

Where is Surrey and Sussex Cancer Alliance based?

Surrey and Sussex Cancer Alliance is headquartered in Guildford, United Kingdom, in the Europe region.

How does Surrey and Sussex Cancer Alliance make money?

One revenue line is on record: NHS England Core Funding.

Does Surrey and Sussex Cancer Alliance have an API?

No public API is recorded for Surrey and Sussex Cancer Alliance.

What industry is Surrey and Sussex Cancer Alliance in?

Surrey and Sussex Cancer Alliance's product category is Healthcare Cancer Care Coordination. Its primary akta.pro industry code is HLAJAMAD, Public Health Governance, Interagency Coordination & Partnerships. Its NAICS code is 813 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales